Advertisement
Products > All
Please find below all kinds of products and services related to organisations from France & Monaco, i.e., the “product portfolio”.Total search results: 1080 | Ordered by Date (ascending)
1 2 3 4 5 6 7 8 9 10 11
Product | Product Group | Organisation | Date |
---|---|---|---|
3D bioprinting_ooo | 3D bioprinting_o | ||
accelerator, particle | analytical instrument_other | ||
ACTIV by Aphea.Bio® biostimulant seed treatment | AGRI LIFE SCIENCES_o | ||
Amazon Web Services (AWS) | cloud computing | Amazon (Group) | |
avian cell line | rPP [recombinant protein production] | ||
BioDiscovery 1 Fund (Edmond de Rothschild) | fund, human health | Andera Partners (FR) | |
BioDiscovery 2 Fund (Edmond de Rothschild) | fund, human health | Andera Partners (FR) | |
BioDiscovery 3 Fund (Edmond de Rothschild) | fund, human health | Andera Partners (FR) | |
BioIntelligence program | database integration software (bioinformatics) | Merck (DE) (Group) | |
biological fish/aquatic treatment | DRUGS, VETERINARY | ||
CD8+ Tregs | T cell therapy | ||
CDMO (CAGT) | contract manufacturing (drugs) | ||
cell line/system (recombinant protein production)_o | rPP [recombinant protein production] | ||
chemical synthesis | chemical and biological services | ||
chemistry (science) | science | ||
clinical research software_o | clinical software tools | ||
coagulation test | diagnostic test | ||
contract research (medical devices) | medical device_o | ||
diagnostic test, breast cancer | diagnostic test | ||
diagnostic test, infection | diagnostic test | ||
diagnostic test, tuberculosis | diagnostic test | ||
Diamicron® | antidiabetic_o | Servier (Group) | |
DNA synthesis | genomic technology | ||
EWOD microfluidics technology | biochip technology (array, bead, lab-on-a-chip)_o | ||
FoxP3+ Tregs | T cell therapy | ||
gene transfer technology | gene therapy technology | ||
genome editing (gene editing) | genomic technology | ||
HER2 expression test | clinical test_other | ||
HPLC (high performance liquid chromatography) | liquid chromatography (LC) | ||
implant_oo | implant | ||
in situ hybridisation (ISH) | molecular diagnostics | ||
infant nutrition | foods & beverages_oo | ||
insulin pump_o | medical pump | ||
KEM® platform (Knowledge Extraction and Management software) | drug discovery software | Ariana Pharmaceuticals (Group) | |
lipid nanoparticle technology (LNP technology) | vector (biotech) | ||
Lm-Technology | drug delivery technology_o | Advaxis Inc. | |
mass spectrometry imaging (MSI) (MALDI imaging) | mass spectrometry (MS) | ||
MDL® Isentris® informatics platform | data integration and analysis software (bioinformatics) | Dassault Systèmes (3DS) (Group) | |
medical device_ooo | medical device_o | ||
Microsoft Azure (MS Azure) | cloud computing | Microsoft (Group) | |
minimally invasive surgical instrument_o | surgical instrument | ||
muconic acid | chemicals (excl. pharmaceuticals)_oo | ||
multiple reaction monitoring (MRM) technology | mass spectrometry (MS) | ||
Novasorb™ drug delivery technology | drug delivery technology_o | Santen (Group) | |
oligo synthesis | genomic technology | ||
oligoDOM® technology platform | vaccine technology | ||
patient recruitment services | clinical research | ||
PET (polyethylene terephthalate) | Petrochemie_s | ||
physics | science | ||
preclinical research | drug development services | ||
ProTide technology | drug development technology | ||
RapidCycler Instrument | real-time thermocycler | Mérieux (Group) | |
recombinant protein production in plant cells_o | rPP [recombinant protein production] | ||
RNA technology_o | genomic technology | ||
RNA-based clinical test | molecular diagnostics | ||
SARS-CoV-2 diagnostic test | clinical test_other | ||
Self-Apposing® coronary stent | stent | Stentys (Group) | |
sepsis test | diagnostic test | ||
Size Exclusion Chromatography (SEC) column | chromatography_other | ||
Sofinnova MD Start II | fund, human health | Sofinnova (Group) | |
sorbitol | food ingredient | ||
surgical instrument_oo | surgical instrument | ||
Surronov® surrogate microorganism (product series) | food safety product | Novolyze (Group) | |
synthetic genome | genomic technology | ||
Toujeo® | insulin | Sanofi (Group) [since May 2011] | |
Type 1 Tregs | T cell therapy | ||
Versius® Surgical Robotic System | surgical instrument | CMR Surgical Ltd. | |
VITEK® 2 60 system | diagnostic device, in vitro | Mérieux (Group) | |
VITEK® 2 XL 120 system | diagnostic device, in vitro | Mérieux (Group) | |
VITEK® system | diagnostic device, in vitro | Mérieux (Group) | |
water analysis services | chemical and biological services | ||
XDotsReader | bioinformatics_oo | Cose (FR) | |
analytical chemistry | science | 1900-01-01 | |
Maalox® | gastrointestinal drug_o | Sanofi (Group) [since May 2011] | 1950-01-01 |
Flagyl® | Sanofi (Group) [since May 2011] | 1957-01-01 | |
easyMAG™ | nucleic acid purification (technology) | Mérieux (Group) | 1969-01-19 |
albumin, human | serum derivate (qm) | Sanofi (Group) [since May 2011] | 1970-01-01 |
Tanakan® | Alzheimer drug | Ipsen (Group) | 1975-01-01 |
Decapeptyl® | cancer drug_o | Ipsen (Group) | 1986-01-01 |
Maxepa® | Pierre Fabre (Group) | 1987-01-01 | |
Stilnox® | Hypnotica / Sedativa_s (qm) | Sanofi (Group) [since May 2011] | 1988-01-01 |
Kybernin® | anticoagulant_o | Sanofi (Group) [since May 2011] | 1988-03-04 |
Clexane® | heparin (class) | Sanofi (Group) [since May 2011] | 1989-01-01 |
Prenalex® | beta-receptor blocker | Servier (Group) | 1989-01-01 |
Ximavon® | Hypnotica / Sedativa_s (qm) | Sanofi (Group) [since May 2011] | 1989-01-01 |
Rifinah® comp. 50 | antibiotic | Sanofi (Group) [since May 2011] | 1989-01-25 |
Ramace® | ACE inhibitor (class 3) | Sanofi (Group) [since May 2011] | 1990-01-01 |
Sargénor | pharmaceutical_oo | Æterna Zentaris (Group) | 1990-01-01 |
Teldane® | antiallergic_o | Sanofi (Group) [since May 2011] | 1990-01-01 |
Isomeride® | obesity drug_o | 1990-07-01 | |
Ponderax® | obesity drug_o | 1990-07-01 | |
Dopacard® | Kardiaka_o [qm] | Sanofi (Group) [since May 2011] | 1991-01-01 |
Orelox® | cefalosporin | Sanofi (Group) [since May 2011] | 1991-01-01 |
Aspégic® | non-steroidal anti-inflammatory drug | Sanofi (Group) [since May 2011] | 1992-01-01 |
Bioclate® | coagulation factor VIII (recombinant) | Sanofi (Group) [since May 2011] | 1992-01-01 |
Calcort 6 | Sanofi (Group) [since May 2011] | 1992-01-01 | |
Carafate® | gastrointestinal drug_o | Sanofi (Group) [since May 2011] | 1992-01-01 |
Dogmatil® | neuroleptic | Sanofi (Group) [since May 2011] | 1992-01-01 |
Ercéfuryl® | pharmaceutical_oo | Sanofi (Group) [since May 2011] | 1992-01-01 |
Primpéran® | gastrointestinal drug_o | Sanofi (Group) [since May 2011] | 1992-01-01 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top